DUBAI, United Arab Emirates, Jan. 17, 2022 (GLOBE NEWSWIRE) — Sales in the global low dosage hydrate inhibitors market are slated to top US$ 75.3 Mn in 2022. Expanding at a healthy 8.1% CAGR, the market size is projected to total US$ 120.3 Mn by 2029. …
